蛋白质组学与缺血性卒中发病风险:ARIC研究与CHS研究的荟萃分析
该研究纳入ARIC与CHS两个队列中基线无卒中的参与者,用适配体检测4954种血液蛋白,通过Cox回归和固定效应荟萃分析发现44种蛋白与缺血性卒中风险显著相关(其中26种为新发现),并在两个独立队列中59%达到复制标准;孟德尔随机化提示MMP12和CNTN1可能与缺血性卒中风险存在因果关联。
要点
- 44种蛋白与缺血性卒中风险显著相关(P<1.0×10-5),其中26种为新发现。
- 在两个独立队列中,37种(84%)关联方向一致,26种(59%)达到复制标准。
- 孟德尔随机化提示MMP12水平较高对缺血性卒中风险有直接保护作用,CNTN1有直接有害作用。
核心结论
- 该蛋白质组与基因组研究识别了新的缺血性卒中风险生物标志物以及2种潜在的病因学CNTN1因素,后者受动脉粥样硬化和肥胖调控。
- 若未来研究证实这些发现,可能对开发新的预防疗法具有意义。
研究设计与样本
- 研究纳入ARIC研究(社区动脉粥样硬化风险研究)和CHS研究(心血管健康研究)在蛋白质组检测时无现患卒中的参与者(ARIC为1990-1992年,CHS为1992-1993年)。
- 用适配体检测血液中蛋白的相对浓度(n=4954)。
- 缺血性卒中事件在ARIC随访至2019年、CHS随访至2015年并经裁定。
- 采用研究特异的Cox回归校正缺血性卒中危险因素,估计蛋白与 incident 缺血性卒中的关联,并用固定效应荟萃分析合并研究特异估计值。
- 在2个独立队列(AGES-Reykjavik、UK Biobank)中进行复制,错误发现率q值<0.05的蛋白被认为达到复制标准。
主要发现
- ARIC和CHS的中位随访时间分别为25年和12年。
- 14139名参与者中有1397名(10%)发生缺血性卒中。
- 44种蛋白与缺血性卒中风险显著相关(P<1.0×10-5),其中26种为新发现。
- 在2个独立队列中,37种(84%)关联方向一致,26种(59%)达到复制标准。
- 孟德尔随机化分析提示MMP12(基质金属蛋白酶-12)和CNTN1(接触蛋白-1)可能与缺血性卒中风险存在因果关联。
关键数值与推荐
- 蛋白与缺血性卒中风险显著相关的阈值:P<1.0×10-5。
- 复制标准:错误发现率q值<0.05。
- 方向一致性:37/44(84%)关联在2个独立队列中方向一致。
- 复制比例:26/44(59%)达到复制标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemic stroke preventive therapies have been slow to emerge due to a limited understanding of the underlying molecular mechanisms. We aimed to discover new protein risk factors that are potential etiologic factors and may be candidates for therapeutic intervention. METHODS: We included ARIC study (Atherosclerosis Risk in Communities) and CHS (Cardiovascular Health Study) participants without prevalent stroke at the time of proteomic profiling (1990-1992 in ARIC and 1992-1993 in CHS). Relative concentrations of proteins in blood were assessed with aptamers (n=4954). Ischemic stroke events were adjudicated through 2019 in ARIC and 2015 in CHS. Study-specific Cox regression adjusting for ischemic stroke risk factors was used to estimate associations between proteins and incident ischemic stroke. Study-specific estimates were combined using fixed-effects meta-analysis. Replication was conducted in 2 independent cohorts (AGES-Reykjavik, UK Biobank). Proteins with a false discovery rate q value <0.05 were considered replicated. Mendelian randomization analyses assessed for potential causal associations between proteins and ischemic stroke. RESULTS: Median follow-up was 25 and 12 years in ARIC and CHS. 1397 out of 14 139 (10%) participants experienced an ischemic stroke. 44 proteins were significantly associated with ischemic stroke risk (P<1.0×10-5), of which 26 are novel. In 2 independent cohorts, 37 (84%) associations were directionally concordant, and 26 (59%) met criteria for replication. Mendelian randomization analyses suggested MMP12 (matrix metallopeptidase-12) and CNTN1 (contactin-1) may be causally related to ischemic stroke risk. In multivariable Mendelian randomization analyses, higher MMP12 levels had a direct protective effect on ischemic stroke risk, while CNTN1 had a direct harmful effect. CONCLUSIONS: This proteomic and genomic investigation of ischemic stroke identified novel risk biomarkers and 2 potential etiologic CNTN1 factors that are regulated in response to atherosclerosis and obesity. If future studies confirm our findings, these results may have implications for the development of new preventive therapies.
引用
- Wang W, Wu Y, Kalani R, et al. Proteomics and Risk of Incident Ischemic Stroke: Meta-Analysis of the ARIC Study and CHS. Stroke. 2026. PMID: 43017770. doi:10.1161/STROKEAHA.125.053518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。